Concepedia

Edward V. Wancewicz

EV

Statistics

Publications

25

Citations

4.5K

H-Index

22

Active since

1981

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of California San Diego

Ludwig Cancer Research

University of California, Santa Cruz

Institute of Cancer Research

Edward V. Wancewicz is an author at Ionis Pharmaceuticals (United States) specializing in molecular biology, life sciences, and antisense rnas.

Publications per year

1981–2019

25

Publications

25

Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43

Magdalini Polymenidou, Clotilde Lagier‐Tourenne, Kasey R. Hutt et al. · Nature Neuroscience · 2011 · 1.4K citations · Full text

, , +14

Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis

Holly Kordasiewicz, Lisa M. Stanek, Edward V. Wancewicz et al. · Neuron · 2012 · 768 citations · Full text

, , +12

Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs

Clotilde Lagier‐Tourenne, Magdalini Polymenidou, Kasey R. Hutt et al. · Nature Neuroscience · 2012 · 750 citations

, , +10

Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals

Eric E. Swayze, Andrew Siwkowski, Edward V. Wancewicz et al. · Nucleic Acids Research · 2006 · 461 citations · Full text

, , +17

Short Antisense Oligonucleotides with Novel 2′−4′ Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in Animals

Punit P. Seth, Andrew Siwkowski, Charles Allerson et al. · Journal of Medicinal Chemistry · 2008 · 267 citations · Full text

, , +17

1–5 of 25